Sotorasib
Back to searchMolecule Structure
Scientific Name
Sotorasib
Description of the Drug
Sotorasib is an experimental KRAS inhibitor being investigated for the treatment of KRAS G12C mutant non small cell lung cancer, colorectal cancer, and appendix cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB15569
http://www.drugbank.ca/drugs/DB15569
Brand Name(s)
Lumakras
Company Owner(s)
Amgen Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
GTPase KRas | SINGLE PROTEIN | INHIBITOR | CHEMBL2189121 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL20560375 | |
Human Metabolome Database | HMDB0304845 | |
DrugBank | DB15569 | |
PubChem | 137278711 | |
BindingDB | 50514402 | |
Metabolights | MTBLC178199 | |
ChemicalBook | CB24858719 | CB65475731 |
Guide to Pharmacology | 10678 | |
ChEBI | 178199 |